Potential diagnostic role of urinary exosomal microRNAs in immunoglobulin A nephropathy: A case-control study

Table 11 Status of the 5 published microRNA markers as observed from our previous study, within 3 comparisons (immunoglobulin A nephropathy vs healthy control, disease control vs healthy control, and immunoglobulin A nephropathy vs disease control)

IgA nephropathy vs healthy control
Probe name	Nephropathy	Control	Ig A nephropathy vs healthy control	P-value of: Nephropathy vs control
hsa-miR-146b-3p	4.07	13.3	-3.27	0.00047341
hsa-miR-221-5p	8.72	14.66	-1.68	0.00512936
hsa-miR-4532	7.01	12.3	-1.76	0.00655229
hsa-miR-599	7.26	16.63	-2.29	0.00649493
hsa-miR-664b-5p	3.85	9.47	-2.46	0.00083272
IgA nephropathy vs disease control
Probe name	Nephropathy	Disease control	IgA nephropathy vs disease control	P-value of: Nephropathy vs disease control
hsa-miR-146b-3p	6.17	8.4	-1.36	0.26787862
hsa-miR-221-5p	11.35	11.84	-1.04	0.73601639
hsa-miR-4532*	8.79	21.09	-2.4	0.04225222
hsa-miR-599	8.66	10.01	-1.16	0.5314607
hsa-miR-664b-5p	5.45	5.32	1.02	0.87722093
Disease control vs healthy control
Probe name	Disease control	Control	Disease control vs healthy control	P-value of: Disease control vs healthy control
hsa-miR-146b-3p	8.4	15.41	-1.83	0.04495602
hsa-miR-221-5p	11.84	18.22	-1.54	0.00787352
hsa-miR-4532	21.09	18.09	1.17	0.68054599
hsa-miR-599	10.01	18.5	-1.85	0.03426054
hsa-miR-664b-5p	5.32	9.86	-1.85	0.0062102

IgA: Immunoglobulin A.